Natera Basic EPS 2014-2025 | NTRA

Natera annual/quarterly basic eps history and growth rate from 2014 to 2025. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
  • Natera basic eps for the quarter ending March 31, 2025 was $-0.50, a 10.71% decline year-over-year.
  • Natera basic eps for the twelve months ending March 31, 2025 was $-1.47, a 52.73% decline year-over-year.
  • Natera annual basic eps for 2024 was $-0.002B, a 59.52% decline from 2023.
  • Natera annual basic eps for 2023 was $-0.004B, a 32.14% decline from 2022.
  • Natera annual basic eps for 2022 was $-0.006B, a 6.91% increase from 2021.
Natera Annual Basic EPS
2024 $-1.53
2023 $-3.78
2022 $-5.57
2021 $-5.21
2020 $-2.84
2019 $-1.79
2018 $-2.22
2017 $-2.58
2016 $-1.95
2015 $-2.68
2014 $-1.07
2013 $-9.66
Natera Quarterly Basic EPS
2025-03-31 $-0.50
2024-12-31 $-0.41
2024-09-30 $-0.26
2024-06-30 $-0.30
2024-03-31 $-0.56
2023-12-31 $-0.63
2023-09-30 $-0.95
2023-06-30 $-0.97
2023-03-31 $-1.23
2022-12-31 $-1.37
2022-09-30 $-1.25
2022-06-30 $-1.50
2022-03-31 $-1.45
2021-12-31 $-1.52
2021-09-30 $-1.63
2021-06-30 $-1.32
2021-03-31 $-0.74
2020-12-31 $-0.92
2020-09-30 $-0.72
2020-06-30 $-0.75
2020-03-31 $-0.45
2019-12-31 $-0.44
2019-09-30 $-0.33
2019-06-30 $-0.48
2019-03-31 $-0.54
2018-12-31 $-0.50
2018-09-30 $-0.49
2018-06-30 $-0.62
2018-03-31 $-0.61
2017-12-31 $-0.88
2017-09-30 $-0.52
2017-06-30 $-0.55
2017-03-31 $-0.63
2016-12-31 $-0.82
2016-09-30 $-0.50
2016-06-30 $-0.46
2016-03-31 $-0.17
2015-12-31 $3.18
2015-09-30 $-0.39
2015-06-30 $-3.58
2015-03-31 $-1.89
2014-12-31
2014-09-30 $0.04
2014-06-30 $-0.11
2013-12-31
Sector Industry Market Cap Revenue
Medical Medical Services $19.262B $1.697B
Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $145.222B 26.93
CVS Health (CVS) United States $74.320B 9.24
Elevance Health (ELV) United States $63.147B 8.49
Cencora (COR) United States $56.296B 19.58
DiDi Global (DIDIY) China $26.168B 27.80
Labcorp Holdings (LH) United States $22.406B 17.68
BioMerieux (BMXMF) France $15.985B 0.00
ICON (ICLR) Ireland $15.748B 15.15
EUROFINS SCIENT (ERFSF) Luxembourg $14.835B 0.00
CochLear (CHEOY) Australia $13.402B 0.00
Medpace Holdings (MEDP) United States $12.801B 33.88
Solventum (SOLV) United States $12.791B 13.54
Revvity (RVTY) United States $12.019B 20.68
Viatris (VTRS) United States $10.974B 3.77
Avantor (AVTR) United States $9.547B 13.87
Sonic Healthcare (SKHHY) Australia $9.287B 0.00
Charles River Laboratories (CRL) United States $8.698B 17.05
HealthEquity (HQY) United States $8.162B 35.75
Caris Life Sciences,�Inc (CAI) United States $7.502B 0.00
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $4.943B 29.10
BrightSpring Health Services (BTSG) United States $3.632B 33.32
Sotera Health (SHC) United States $3.437B 19.53
Surgery Partners (SGRY) United States $2.693B 35.02
Organon (OGN) United States $2.618B 2.78
Concentras Parent (CON) United States $2.517B 14.55
GeneDx Holdings (WGS) United States $2.324B 89.50
Alignment Healthcare (ALHC) United States $2.303B 0.00
Progyny (PGNY) United States $1.972B 43.40
GoodRx Holdings (GDRX) United States $1.775B 35.50
Premier (PINC) United States $1.747B 13.26
PACS (PACS) United States $1.742B 0.00
Ardent Health (ARDT) United States $1.543B 6.58
Teladoc Health (TDOC) United States $1.439B 0.00
Establishment Labs Holdings (ESTA) $1.248B 0.00
Pediatrix Medical (MD) United States $1.067B 8.12
QDM (QDMI) Hong Kong, SAR China $0.997B 342.00
Ryman Healthcare (RYHTY) New Zealand $0.970B 0.00
Agilon Health (AGL) United States $0.857B 0.00
AMN Healthcare Services Inc (AMN) United States $0.750B 7.03
CareDx (CDNA) United States $0.715B 11.16
Embecta (EMBC) United States $0.665B 4.48
Nutex Health (NUTX) United States $0.532B 8.05
InnovAge Holding (INNV) United States $0.513B 0.00
SBC Medicals (SBC) United States $0.505B 0.00
Omada Health (OMDA) $0.486B 0.00
LifeMD (LFMD) United States $0.485B 0.00
So-Young (SY) China $0.480B 0.00
Auna S.A (AUNA) Luxembourg $0.469B 10.55
Sonida Senior Living (SNDA) United States $0.463B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.409B 0.00
Enhabit (EHAB) United States $0.349B 28.71
Oncology Institute (TOI) United States $0.326B 0.00
Performant Healthcare (PHLT) United States $0.287B 0.00
Beauty Health (SKIN) United States $0.231B 0.00
Pheton Holdings (PTHL) China $0.187B 0.00
DocGo (DCGO) United States $0.148B 24.17
Sera Prognostics (SERA) United States $0.122B 0.00
Ascend Wellness Holdings (AAWH) United States $0.083B 0.00
KindlyMD (NAKA) United States $0.080B 0.00
Biodesix (BDSX) United States $0.061B 0.00
NeueHealth (NEUE) United States $0.060B 0.00
IceCure Medical (ICCM) Israel $0.058B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.045B 0.00
ModivCare (MODV) United States $0.044B 0.00
Basel Medical Group (BMGL) Singapore $0.041B 0.00
OSR Holdings (OSRH) United States $0.019B 0.00
Intelligent Bio Solutions (INBS) United States $0.013B 0.00
Co-Diagnostics (CODX) United States $0.010B 0.00
BioNexus Gene Lab (BGLC) $0.009B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.006B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00